Agilent Technologies and ExonHit Expand Agreement for Agilent to Market and Sell ExonHit SpliceArrays worldwide

The two companies announced that they have entered into a marketing alliance in which Agilent will market and sell nine different ExonHit human and mouse SpliceArrays as commercial products, including GPCR, Ion Channel, nuclear receptors and apoptosis pathways.

Source: Agilent Technologies